Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.01B | 23.16B | 23.61B | 20.71B | 20.41B | 20.01B |
Gross Profit | 23.95B | 24.01B | 23.63B | 22.11B | 21.92B | 21.58B |
EBITDA | 3.52B | 3.33B | 3.06B | 3.50B | 3.20B | 2.97B |
Net Income | 1.82B | 1.82B | 1.53B | 1.88B | 1.66B | 1.52B |
Balance Sheet | ||||||
Total Assets | 1.36T | 1.36T | 1.34T | 1.31T | 1.40T | 1.30T |
Cash, Cash Equivalents and Short-Term Investments | 108.83B | 108.83B | 101.97B | 86.59B | 196.34B | 103.46B |
Total Debt | 39.98B | 39.98B | 39.75B | 25.44B | 120.55B | 26.77B |
Total Liabilities | 1.31T | 1.31T | 1.29T | 1.26T | 1.35T | 1.25T |
Stockholders Equity | 55.86B | 55.86B | 56.83B | 54.20B | 54.75B | 51.81B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 14.90B | -3.37B | -110.62B | 90.10B | 46.66B |
Operating Cash Flow | 0.00 | 15.32B | -3.02B | -110.25B | 90.73B | 47.32B |
Investing Cash Flow | 0.00 | -26.13B | 8.86B | 2.06B | -13.00M | -10.85B |
Financing Cash Flow | 0.00 | 17.39B | 17.55B | -828.00M | 2.17B | -806.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥10.14B | 7.15 | 4.01% | 2.44% | 10.20% | ||
73 Outperform | ¥12.69B | 9.82 | 3.71% | 9.46% | 9.41% | ||
72 Outperform | ¥12.89B | 11.15 | 3.68% | 7.67% | -26.27% | ||
72 Outperform | ¥17.06B | 6.96 | 3.59% | 14.06% | 20.87% | ||
69 Neutral | ¥16.01B | 11.13 | 3.59% | 2.61% | -7.91% | ||
69 Neutral | ¥22.68B | 10.28 | 3.05% | 0.44% | ― | ||
68 Neutral | $17.80B | 11.94 | 9.89% | 3.74% | 9.69% | 1.17% |